PL380103A1 - Środek do zapobiegania i/lub hamowania kolonizacji Helicobater pylori i zastosowanie - Google Patents

Środek do zapobiegania i/lub hamowania kolonizacji Helicobater pylori i zastosowanie

Info

Publication number
PL380103A1
PL380103A1 PL380103A PL38010306A PL380103A1 PL 380103 A1 PL380103 A1 PL 380103A1 PL 380103 A PL380103 A PL 380103A PL 38010306 A PL38010306 A PL 38010306A PL 380103 A1 PL380103 A1 PL 380103A1
Authority
PL
Poland
Prior art keywords
preventing
colonization
inhibiting
agent
application
Prior art date
Application number
PL380103A
Other languages
English (en)
Other versions
PL226695B1 (pl
Inventor
Danuta Kruszewska
Original Assignee
Danuta Kruszewska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danuta Kruszewska filed Critical Danuta Kruszewska
Priority to PL380103A priority Critical patent/PL226695B1/pl
Priority to US12/452,485 priority patent/US20100124537A1/en
Priority to ES07460015T priority patent/ES2360142T3/es
Priority to DK07460015.6T priority patent/DK1917959T3/da
Priority to EP07460015A priority patent/EP1917959B1/en
Priority to AT07460015T priority patent/ATE495738T1/de
Priority to DE602007012036T priority patent/DE602007012036D1/de
Priority to SI200730571T priority patent/SI1917959T1/sl
Priority to PL07460015T priority patent/PL1917959T3/pl
Publication of PL380103A1 publication Critical patent/PL380103A1/pl
Priority to HR20110268T priority patent/HRP20110268T1/hr
Priority to IL233342A priority patent/IL233342A/en
Publication of PL226695B1 publication Critical patent/PL226695B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Ujawniono środek do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori. Środek jako substancję czynną zawiera sole kwasu alfa-ketoglutarowego. Przedstawiono także zastosowanie soli kwasu alfa-ketoglutarowego.
PL380103A 2006-07-03 2006-07-03 Środek do zastosowania w zapobieganiu i/lub hamowaniu kolonizacji Helicobacter pylori, zastosowanie soli kwasu alfa‑ketoglutarowego z metalami alkalicznymi i ziem alkalicznych do wytwarzania środka leczniczego oraz dodatku do żywności do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori PL226695B1 (pl)

Priority Applications (11)

Application Number Priority Date Filing Date Title
PL380103A PL226695B1 (pl) 2006-07-03 2006-07-03 Środek do zastosowania w zapobieganiu i/lub hamowaniu kolonizacji Helicobacter pylori, zastosowanie soli kwasu alfa‑ketoglutarowego z metalami alkalicznymi i ziem alkalicznych do wytwarzania środka leczniczego oraz dodatku do żywności do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori
AT07460015T ATE495738T1 (de) 2006-07-03 2007-07-03 Neue medizinische verwendung von alpha- ketoglutarat
ES07460015T ES2360142T3 (es) 2006-07-03 2007-07-03 Nuevo uso médico de alfa-cetoglutarato.
DK07460015.6T DK1917959T3 (da) 2006-07-03 2007-07-03 En ny medicinsk anvendelse af alfa-ketoglutarat
EP07460015A EP1917959B1 (en) 2006-07-03 2007-07-03 New medical use of alfa-ketoglutarate
US12/452,485 US20100124537A1 (en) 2006-07-03 2007-07-03 Medical applications of alpha-ketoglutarate
DE602007012036T DE602007012036D1 (de) 2006-07-03 2007-07-03 Neue medizinische Verwendung von Alpha-Ketoglutarat
SI200730571T SI1917959T1 (sl) 2006-07-03 2007-07-03 Nova medicinska uporaba alfa-ketoglutarata
PL07460015T PL1917959T3 (pl) 2006-07-03 2007-07-03 Nowe medyczne zastosowanie alfa-ketoglutaranu
HR20110268T HRP20110268T1 (hr) 2006-07-03 2011-04-13 Nova medicinska primjena alfa-ketoglutarata
IL233342A IL233342A (en) 2006-07-03 2014-06-24 A process for making organic biofuel and accelerating conversion to biofuel production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL380103A PL226695B1 (pl) 2006-07-03 2006-07-03 Środek do zastosowania w zapobieganiu i/lub hamowaniu kolonizacji Helicobacter pylori, zastosowanie soli kwasu alfa‑ketoglutarowego z metalami alkalicznymi i ziem alkalicznych do wytwarzania środka leczniczego oraz dodatku do żywności do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori

Publications (2)

Publication Number Publication Date
PL380103A1 true PL380103A1 (pl) 2008-01-07
PL226695B1 PL226695B1 (pl) 2017-08-31

Family

ID=38984524

Family Applications (2)

Application Number Title Priority Date Filing Date
PL380103A PL226695B1 (pl) 2006-07-03 2006-07-03 Środek do zastosowania w zapobieganiu i/lub hamowaniu kolonizacji Helicobacter pylori, zastosowanie soli kwasu alfa‑ketoglutarowego z metalami alkalicznymi i ziem alkalicznych do wytwarzania środka leczniczego oraz dodatku do żywności do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori
PL07460015T PL1917959T3 (pl) 2006-07-03 2007-07-03 Nowe medyczne zastosowanie alfa-ketoglutaranu

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL07460015T PL1917959T3 (pl) 2006-07-03 2007-07-03 Nowe medyczne zastosowanie alfa-ketoglutaranu

Country Status (10)

Country Link
US (1) US20100124537A1 (pl)
EP (1) EP1917959B1 (pl)
AT (1) ATE495738T1 (pl)
DE (1) DE602007012036D1 (pl)
DK (1) DK1917959T3 (pl)
ES (1) ES2360142T3 (pl)
HR (1) HRP20110268T1 (pl)
IL (1) IL233342A (pl)
PL (2) PL226695B1 (pl)
SI (1) SI1917959T1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
PL2046334T3 (pl) 2006-07-25 2015-02-27 Vecta Ltd Kompozycje i sposoby hamowania wydzielania kwasów żołądkowych z wykorzystaniem pochodnych małych kwasów dikarboksylowych w połączeniu z PPI
SE0602446L (sv) * 2006-11-16 2008-05-17 Entress Ab Ny användning av kända farmakologiskt aktiva kemiska sammansättningar
EP2468319B1 (en) 2010-11-29 2016-11-23 Eurochit Danuta Kruszewska New nanoproduct useful in prophilaxis, diagnostics and medical and veterinary treatment
CN104684565A (zh) 2012-05-29 2015-06-03 达努塔·克鲁谢夫斯卡 在人类和兽医的预防和医疗中有用的、包含罗伊氏乳杆菌dan080的纳米产品及其医疗用途
EP2674162A1 (en) 2012-05-29 2013-12-18 Danuta Kruszewska Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
CA2884592C (en) 2012-09-19 2021-08-31 Grespo Ab Compositions for improvement of brain function
CN103923900B (zh) * 2014-04-14 2016-03-23 江南大学 一种黄酒用双功能酶交联酶聚集体的制备与应用
EP3518915A4 (en) * 2016-09-30 2020-04-15 The Regents of the University of California ALPHA KETOBUTYRATE, ALPHA KETOGLUTARATE AND 2-HYDROXYBUTYRATE FOR STIMULATING HAIR GROWTH
SG10202107237SA (en) * 2017-04-25 2021-08-30 Buck Inst Res Aging Formulations for extending lifespan and healthspan
KR102833111B1 (ko) 2018-09-25 2025-07-10 폰세 드 리온 헬스 데지그네이티드 액티비티 컴퍼니 칼슘 알파-케토글루타레이트의 제조 방법
WO2020086733A1 (en) * 2018-10-24 2020-04-30 Ponce De Leon Health Designated Activity Company Nicotinamide riboside compositions for healthspan extension
CA3188646A1 (en) * 2020-07-02 2022-01-06 Ponce De Leon Health Designated Activity Company Compositions and methods for treating crp-mediated diseases
CN115340313B (zh) * 2022-01-17 2023-04-18 浙江理工大学 一种物理复合微生物技术强化再生骨料方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4919855B1 (pl) 1970-10-06 1974-05-21
US4256731A (en) * 1978-03-23 1981-03-17 Beecham, Inc. Oral Compositions
US5028412A (en) * 1987-05-01 1991-07-02 Purdue Research Foundation Oral compositions comprising anti-calculus agents
US5817294A (en) * 1990-11-02 1998-10-06 Arnold; Michael J. Plaque adsorbent oral composition and method
JP2002529545A (ja) * 1998-11-06 2002-09-10 ユニベルシテ ドゥ モントリオール バイオフィルムを除去するための改良型の殺菌性及び非殺菌性溶液
FR2822704B1 (fr) * 2001-03-29 2005-02-18 Chiesi Sa Sels de cetoacides et d'acides amines gastroresistants et leur utilisation pour la preparation de medicaments
US7122578B2 (en) * 2001-09-11 2006-10-17 Alain Martin Method and composition for treating mammalian diseases and injuries which cause pain, erythema, swelling, crusting, ischemia scarring and excess white blood cell infiltration
SE0200256D0 (sv) * 2001-12-21 2002-01-29 Gramineer Internat Ab New composition, methods and use
PL368572A1 (pl) * 2004-06-17 2005-12-27 Sgp & Sons Ab Preparat farmaceutyczny do stosowania w profilaktyce i leczeniu podwyższonego poziomu cholesterolu,LDL oraz trójglicerydów oraz zastosowanie preparatu farmaceutycznego jako czynnika przeciwmiażdżycowego stosowanego w schorzeniach układu krążenia
US7803817B2 (en) * 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
AU2006316059A1 (en) 2005-11-15 2007-05-24 Entress Ab Medicament for use in connection with cartilage impairment
KR20080102372A (ko) * 2006-01-19 2008-11-25 엔트레스 에이비 진단 방법 및 치료 방법

Also Published As

Publication number Publication date
SI1917959T1 (sl) 2011-05-31
PL226695B1 (pl) 2017-08-31
IL233342A0 (en) 2014-08-31
EP1917959B1 (en) 2011-01-19
PL1917959T3 (pl) 2011-06-30
IL233342A (en) 2016-05-31
DE602007012036D1 (de) 2011-03-03
DK1917959T3 (da) 2011-05-09
US20100124537A1 (en) 2010-05-20
EP1917959A1 (en) 2008-05-07
ES2360142T3 (es) 2011-06-01
HRP20110268T1 (hr) 2011-05-31
ATE495738T1 (de) 2011-02-15

Similar Documents

Publication Publication Date Title
PL380103A1 (pl) Środek do zapobiegania i/lub hamowania kolonizacji Helicobater pylori i zastosowanie
EP2349279A4 (en) MODIFIERS OF ALDEHYDE DEHYDROGENASE AND METHODS OF USE THEREOF
EP2184984A4 (en) DERIVATIVES OF N- (ARYLAMINO) SULPHONAMIDES WITH POLYMORPHES AS MEK-INHIBITORS AND COMPOSITIONS THEREOF, METHOD FOR THEIR USE AND METHOD FOR THEIR PREPARATION
EP2234963A4 (en) LEVODOPA FORMULATIONS WITH CONTROLLED RELEASE AND ITS USE
JO2962B1 (en) Aminopronic derivatives substituted as niprilicin inhibitors
EA201200049A1 (ru) 1,3-дизамещенные производные имидазолидин-2-она в качестве ингибиторов cyp 17
IL198979A (en) Enzyme inhibitors diacylglycerol o-acetyltransferase type 1
NO20090175L (no) Stabile laquinimod sammensetninger
NO20083836L (no) N-hydroksyakrylamidforbindelser
WO2006066133A3 (en) Histone deacetylase inhibitors
PL402389A1 (pl) Sposób hamowania aktywnosci kinazy Raf u ludzi lub zwierzat
TW200716183A (en) Parakeratosis inhibitor, pore-contracting agent and external composition for skin
UA109547C2 (uk) Композиція для боротьби з захворюванням рослин і спосіб боротьби з захворюванням рослин
EP2079462A4 (en) PHARMACEUTICAL COMPOSITIONS OF HDAC INHIBITORS AND CHELABLE METAL COMPOUNDS AND METALO HDAC HEMMER CHELATE COMPLEXES
PA8846901A1 (es) Inhibidores de cinasa akt y p70 s6.
TN2009000451A1 (en) Intrvenous and oral dosing of a direct-acting and reversible p2y12 inhibitor
NO20075111L (no) Farmasoytisk sammensetning
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
EA201170483A1 (ru) Твердая фармацевтическая композиция
EA200900631A1 (ru) Замещённые пиразолы и триазолы, как ингибиторы кбв (кинезин-белок веретена)
MX2009006638A (es) Agente para erradicar helicobacter pylori que tiene actividad inhibidora sobre la secrecion de acido gastrico.
BRPI0516077A (pt) composições antimicrobianas compreendendo um agente natural selecionado de ácido gálico, eucalipotol, naringina, um composto de ácido jasmÈnico e qualquer combinação destes
TW200800951A (en) Substituted imidazole compounds as KSP inhibitors
TW200716184A (en) Inhibitor for parakeratosis, pore reducing agent or skin roughening preventing or ameliorating agent and composition for skin care preparation
UY31058A1 (es) Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios